HealthQuill breast cancer risk
women exercising in a group for elderly
Drugs Health Research

FDA removes black box warnings on HRT drugs after two decades

The US Food and Drugs Administration has initiated the removal of the black box warning from menopausal hormone replacement therapy (HRT) products, marking.

Read More
AstraZeneca, Daiichi’s breast cancer drug trial results show improvement in progression-free survival
Health Research

Research reveals first child after age 30 increases breast cancer risk by over 40%

HQ Team August 18, 2025: Research finds that women who have their first child after age 30 face a 40% to 45% higher.

Read More
Merck & Co., Inc., announced it has met one of the primary goals during a late-stage trial of its breast cancer therapy, Keytruda.
Health Medical

Hormonal contraceptives and breast cancer risk in BRCA1 carriers

HQ Team January 17, 2025: A study has found a significant association between the use of hormonal contraceptives and an increased risk of.

Read More
Drugs Health Medical Pharma

Novartis’ Kisqali shows 25% reduction in breast cancer recurrence

HQ Team June 3, 2023: Novartis breast cancer drug Kisqali cut the risk of recurrence of the disease by more than 25% in.

Read More
Granules India announced the US Food & Drug Administration (US FDA) had approved an Abbreviated New Drug Application (ANDA) for losartan potassium tablets to treat high blood pressure.
Health Medical

Contraceptive pills ‘slightly’ increase risk of breast cancer, says study

Progestin-only contraceptive use increases breast cancer risk similarly to combined contraceptive use.

Read More